BREAKING NEWS Nevada rocked by earthquake swarm with the strongest reaching nearly 5 magnitude
The US Geological Survey (USGS) detected seven earthquakes, with the largest measuring a 4.8 magnitude, that hit at 7:16am ET near Caliente.
The other tremors, starting Thursday and continuing into Friday, ranged from 1.1 magnitude to 3.3 magnitude.
The 4.8 magnitude is the latest earthquake to hit, with shaking detected as far south as Las Vegas, which sits more than 150 miles south.
It was likely caused by tectonic activity along one of the many fault systems in the Basin and Range Province, a region known for stretching and thinning of the Earth's crust.
The USGS detect a 3.3 magnitude earthquake Thursday about 14 miles northeast of Nellis Air Force Base. This was followed by two smaller tremors just minutes later.
Nellis Air Force Base tested US nuclear weapons above ground during the 1950s and 1960s, but testing moved underground until all operations ceased in 1992.
Nevada is the nation's third-most seismically active state, ranking behind only California and Alaska.
This is a developing story... More updates to come
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
6 hours ago
- The Independent
Fault line on Canadian border thought dormant for years could cause major earthquake, new study shows
A fault line on the Canadian border, thought to be dormant for tens of millions of years, could cause a major earthquake, a new study has revealed. The Tintina fault stretches about 600 miles from northeastern British Columbia into Alaska. It was previously thought to have last been active around 40 million years ago. But a study published in Geophysical Research Letters earlier this month found signs of more recent activity. New topographic data collected from satellites, airplanes and drones showed about an 80-mile-long segment of the fault where 2.6 million-year-old and 132,000-year-old geological formations are laterally shifted across the fault. 'We further show that the fault has not ruptured in a major earthquake for at least 12 thousand years, and could generate an earthquake of at least magnitude 7.5 in the future,' the study read. 'The Tintina fault therefore represents an important, previously unrecognized, seismic hazard to the region.' An earthquake with a 7 to 7.9 magnitude is considered major and can create serious damage, according to Michigan Tech. These types of earthquakes are fairly rare, with only 10 to 15 estimated to occur each year. Michigan Tech warns earthquakes with a magnitude of 8 or greater, which typically occur only once every year or two, can destroy communities near the epicenter. 'Based on the data, we think that the fault may be at a relatively late stage of a seismic cycle, having accrued a slip deficit, or build-up of strain, of six meters in the last 12,000 years,' Theron Finley, a recent University of Victoria phD graduate and lead author of the new study, explained in SciTechDaily. 'If this were to be released, it would cause a significant earthquake.' Dr. Michael West, state seismologist at the Alaska Earthquake Center, told the Mail, 'It is one of the least studied fault systems in North America, and that needs to change.'
Reuters
6 hours ago
- Reuters
Russia's Roscosmos, NASA to hold first in-person talks at heads level since 2018, Russia says
July 29 (Reuters) - The head of Russian space agency Roscosmos, Dmitry Bakanov, has arrived in Houston for talks with the interim head of NASA, Sean Duffy - the first in-person meeting at the agencies' heads level since 2018, Russian news agencies reported on Tuesday. Talks between Bakanov, the head of Roscosmos since February, and U.S. Transportation Secretary Duffy, whom President Donald Trump named as NASA's interim head earlier this month, are scheduled for July 31, Russia's TASS state news agency reported. "The parties plan to discuss ongoing joint projects," TASS reported, citing a Roscosmos statement. The space program is one of the few international projects on which the United States and Russia still cooperate closely. Relations in other areas between the two countries have broken down since Russia's invasion of Ukraine in 2022. "We plan to discuss the continuation of the cross-flight program, the extension of the International Space Station's operational life, and the work of the Russia-U.S. joint task force on the future safe deorbiting and controlled ocean disposal of the ISS," TASS cited Bakanov as saying in the Roscosmos statement. Bakanov met with NASA Associate Administrator for Space Operations Ken Bowersox in April at the Russian-operated Baikonur Cosmodrome in Kazakhstan, according to TASS. But the last meeting between the heads of Roscosmos and NASA took place in October 2018, when Dmitry Rogozin, then director general of Roscosmos, met NASA Administrator Jim Bridenstine in person also at the Baikonur Cosmodrome, according to Russian media. Bakanov, together with NASA officials, will visit divisions of the Johnson Space Center and Boeing's (BA.N), opens new tab production facility for talks with the company's space program leadership, RIA agency reported. On the eve of the launch of NASA's SpaceX Crew-11 flight, scheduled for July 31, Bakanov will meet with the crew of the Crew Dragon spacecraft, which includes Roscosmos cosmonaut Oleg Platonov, RIA reported. In the early days after Trump's return to office in January, Russia and the U.S. moved closer to restore relations, but the U.S. president has since grown impatient with Moscow, giving Russia on Monday 10-12 days to make progress toward ending the war in Ukraine.
Reuters
7 hours ago
- Reuters
Sarepta resumes shipping of gene therapy Elevidys to patients who can walk
July 28 (Reuters) - Sarepta Therapeutics (SRPT.O), opens new tab said on Monday it will resume shipping of its gene therapy Elevidys to patients with a rare muscular disorder who can walk, after the FDA recommended the removal of a voluntary hold that was placed on the therapy. However, the use of the gene therapy remains on hold for Duchenne Muscular Dystrophy patients who cannot walk, the FDA said, adding that it is continuing to work with the company while investigating the death of two patients. The FDA's recommendation for ambulatory patients - those who can walk - followed a probe that showed the death of an eight-year-old boy in Brazil, was unrelated to the gene therapy, the agency said. Roche, which has partnered with Sarepta for commercialization outside the U.S., had previously said the patient's death was not related to the therapy, according to the reporting physician's assessment. Sarepta is also facing intense scrutiny following the death of two non-ambulatory teenage boys associated with Elevidys, as well as a 51-year-old man who had received its experimental gene therapy SRP-9004.
